Recent Harvard Mumps Outbreak Occurred only Among Vaccinated Students*
Many people are already aware of the mumps outbreak at Harvard University that has spread to forty students, developing in recent weeks from two isolated cases that were discovered on campus earlier this year in late February.
The irony of this outbreak is that it has occurred only among vaccinated students.
The MMR vaccine against measles, mumps, and rubella has long been the subject of controversy, with its connection to autism, earning a starring role in the highly publicized recent documentary Vaxxed.
Now, you will learn why the MMR vaccine has more reasons to be criticized than just for its role in creating symptoms of autism in children.
Why Aren’t The MMR Vaccines Working?
Dr. Amesh Adalja, an infectious disease specialist at the University of Pittsburgh’s Center for Health Security, claims that vaccines are not strong enough to provide sufficient antibodies to people who live in the close living spaces of college dormitories.
“The exposure that they have to mumps is so high in these situations that it overcomes the ability of the vaccine to protect them.”
According to neurologist Dr. Russell Blaylock, vaccines actually decrease cellular immunity, which is much more critical for disease protection than antibody levels. Dr. Blaylock’s research also demonstrates that if any immunity is actually provided from vaccines, it is limited.
For more information about the MMR vaccine, read our widely shared article, You Decide: The Risks and Benefits of the MMR Vaccine.
The Sad Truth about the MMR Vaccine, According to Merck’s Own Researchers
In addition to the disturbing fact that there has never been a proper scientific study comparing cases of mumps among vaccinated and unvaccinated people, Merck falsified data regarding their MMR vaccine, as discovered and reported by two Merck scientists. They reported this unethical behaviour in 2010, stating that researchers altered blood samples with animal antibodies and fraudulently claimed the vaccine was 95% effective, when, in reality, it was not.
What Most People Don’t Know About Mumps
According to the Centers for Disease Control and Prevention (CDC), mumps are often a relatively benign disease. Their website lists the most common symptoms, including fever, headache, muscle aches, tiredness, loss of appetite, and swollen, tender salivary glands. They also state, “Some people who get mumps have very mild or no symptoms, and often they do not know they have the disease. Most people with mumps recover completely in a few weeks.”
The CDC also states that “mumps is less contagious than measles or chickenpox,” which seems to contradict the “experts” who claim the mumps outbreak is occurring at Harvard because it is highly contagious, rather than admitting that the vaccine companies who provide millions of dollars in funding to the medical school have produced a faulty, ineffective vaccine.
What Harvard Is Hiding
This mumps outbreak offers a little bit of irony to discerning readers: it is taking place at a medical school that earned an “F” from students for the exuberant amount of funding it receives from pharmaceutical companies, including those who have made the vaccines that aren’t providing immunity to Harvard’s students.
In just one year, pharmaceutical companies gave $11.5 million in donations to Harvard for classes and research.
Some students have spoken out against the conflict of interest that arises when pharmaceutical companies provide large amounts of funding to Harvard and other medical schools. The American Student Medical Association, a national organization that rates medical schools according to how much drug industry money they use, gave Harvard an “F,” the lowest possible grade.
Even more disturbing than the student rating was what Harvard’s own faculty members had to say about the subject: 1600 of 8900 professors and lecturers admitted that “they or a family member have ties to drug companies that could bias their teaching or research,” including 130 with financial ties to Merck and 149 with financial ties to Pfizer. That’s nearly 20 percent of Harvard’s teaching staff.
Some Harvard Medical School faculty members are not required to report specific earnings from consulting or speaking fees, and there are no limits on the value of gifts faculty members can receive, including meals, trips, and tickets.
Finally, a former leader of Harvard’s immunology lab also held a position, at the same time, on the corporate board of directors at Bristol-Myers Squibb, a pharmaceutical company. They gave her a $270,000 paycheck while she was in charge of immunology at Harvard.
The mumps outbreak at Harvard medical school among vaccinated students is not shocking news. Informed readers know that vaccines do not provide safe, effective, lasting immunity against diseases. Merck’s own employees have accused their colleagues of falsifying data to promote their vaccine as a highly effective method of preventing the spread of mumps, a claim that is untrue.
Meanwhile, Harvard and other institutions who receive funding from vaccine makers claim a disease is highly contagious, rather than blaming a vaccine that doesn’t work.